Chiesi Limited is headquartered in Manchester and employs over 400 people. Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused group with over 85 years’ experience in the pharmaceutical sector operating in 30 countries, employing around 6,000 people. To achieve its mission of improving people’s quality of life by acting responsibly towards society and the environment, Chiesi researches, develops and markets drugs in its three therapeutic areas: AIR (respiration, from new-born to adult populations), RARE (rare and ultra-rare diseases) and CARE (special care and consumer-facing self-care). Chiesi, since 2019, is the world’s largest B Corp certified pharmaceutical group.
Further information: www.chiesi.uk.com
Contact us: email@example.com
An error occurred trying to play the stream. Please reload the page and try again.Close
Dr Pipin Singh is a GP partner, trainer and clinical author in Wallsend, Tyne and Wear. He is a diabetes practice lead and has an interest in men's health. He is also a training programme director for Northumbria GP Training Programme. His hobbies include snooker, tennis, running and general fitness.
Dr Vincent McGovern is a general practitioner with a special interest in respiratory medicine working in the Belfast Trust. He previously held three part-time clinical assistantships, all for over twenty years, one in adult chest medicine at Belfast City Hospital, one in paediatric asthma at the Royal Belfast Hospital for Sick Children and one in accident and emergency medicine at the Ulster Hospital Dundonald. Dr McGovern carries out Pulmonary Rehabilitation assessment and early COPD detection clinics in the community and was on the steering committee of the National Review of Asthma Deaths.